Drawing for BOC SCIENCES

USPTO serial 99798674

BOC SCIENCES

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LORENZO, KATHLEEN H
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with BOC SCIENCES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David Lin

1001 162ND ST4DWhitestone, NY 11357

Goods and services

ClassDescriptionStatusFirst use
042Bacteriological consultation and research; Bacteriological research and testing; Biochemical research and development; Biomedical research services; Biotechnology research; Chemical analysis; Chemical laboratories; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Chemist services; Chemistry consultation; Compiling data for research purposes in the field of medical science and medical consultancy; Custom design and development of chemical reagents and biochemical assays; Design and testing of new products for others; Design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; Development and test of chemical production methods; Development of pharmaceutical preparations and medicines; DNA analysis services for scientific research purposes; Drug discovery services; Executing of chemical analyses; Genetic mapping for scientific purposes; Genetic testing of laboratory animals for research purposes; Laboratory research services relating to pharmaceuticals; Laboratory services, namely, pigment and color analysis; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research information in the field of drug discovery; Medical research services in the field of cancer; Performance of chemical analyses; Pharmaceutical products development; Pharmaceutical research services; Product testing; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of technology in the field of drug discovery; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research and development; Scientific research for medical purposes in the field of drug discovery, medicine, the prevention, treatment and management of illness, health care delivery, and cancerous diseases; Technological planning and consulting services in the field of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogeneticsACTIVEJan 1, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 27, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 21, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 29, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 28, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 28, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 28, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 10, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 4, 2026DOCKASSIGNED TO EXAMINER—
Sep 2, 2026MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 2, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 30, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 30, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance